
  <style>
  .gh-table table { 
    border-collapse: collapse; 
    width: 100%;
    border: 1px solid #444;
    font-size: 12px;
  }
  .gh-table th, .gh-table td { 
    border: 1px solid #444; 
    padding: 4px 6px; 
    vertical-align: top;
    font-weight: 400 !important;   /* regular font */
  }
  .gh-table th { 
    .gh-table th { background: #f5f5f5; text-align: left; }
  }
  .gh-table th { font-weight: 700 !important; }
    @media print {
      .gh-table { font-size: 10px; }
    }
  </style>
  <div class='gh-table'><table><thead><tr><th>record_id</th><th>visit</th><th>Molecola (1)</th><th>Molecola (2)</th><th>description</th></tr></thead><tbody><tr><td>B120</td><td>1</td><td>Finasteride</td><td>Acetylsalicylic acid</td><td>The risk or severity of hypertension can be increased when Acetylsalicylic acid
is combined with Finasteride.</td></tr><tr><td>B120</td><td>1</td><td>Levodopa</td><td>Lorazepam</td><td>The risk or severity of CNS depression can be increased when Lorazepam is
combined with Levodopa.</td></tr><tr><td>B120</td><td>1</td><td>Levodopa</td><td>Methotrimeprazine</td><td>Levodopa may increase the central nervous system depressant (CNS depressant)
activities of Methotrimeprazine.</td></tr><tr><td>B120</td><td>1</td><td>Levodopa</td><td>Nebivolol</td><td>The risk or severity of hypotension and orthostatic hypotension can be increased
when Nebivolol is combined with Levodopa.</td></tr><tr><td>B120</td><td>1</td><td>Levodopa</td><td>Tapentadol</td><td>Tapentadol may increase the central nervous system depressant (CNS depressant)
activities of Levodopa.</td></tr><tr><td>B120</td><td>1</td><td>Levodopa</td><td>Valproic acid</td><td>The risk or severity of CNS depression can be increased when Valproic acid is
combined with Levodopa.</td></tr><tr><td>B120</td><td>1</td><td>Lorazepam</td><td>Acetylsalicylic acid</td><td>Acetylsalicylic acid may decrease the excretion rate of Lorazepam which could
result in a higher serum level.</td></tr><tr><td>B120</td><td>1</td><td>Lorazepam</td><td>Valproic acid</td><td>The serum concentration of Lorazepam can be increased when it is combined with
Valproic acid.</td></tr><tr><td>B120</td><td>1</td><td>Methotrimeprazine</td><td>Acetylsalicylic acid</td><td>The risk or severity of hypertension can be increased when Acetylsalicylic acid
is combined with Methotrimeprazine.</td></tr><tr><td>B120</td><td>1</td><td>Methotrimeprazine</td><td>Finasteride</td><td>The risk or severity of hypertension can be increased when Finasteride is
combined with Methotrimeprazine.</td></tr><tr><td>B120</td><td>1</td><td>Methotrimeprazine</td><td>Lorazepam</td><td>Lorazepam may increase the central nervous system depressant (CNS depressant)
activities of Methotrimeprazine.</td></tr><tr><td>B120</td><td>1</td><td>Methotrimeprazine</td><td>Nebivolol</td><td>The metabolism of Nebivolol can be decreased when combined with
Methotrimeprazine.</td></tr><tr><td>B120</td><td>1</td><td>Methotrimeprazine</td><td>Valproic acid</td><td>Valproic acid may increase the central nervous system depressant (CNS
depressant) activities of Methotrimeprazine.</td></tr><tr><td>B120</td><td>1</td><td>Nebivolol</td><td>Acetylsalicylic acid</td><td>Acetylsalicylic acid may decrease the antihypertensive activities of Nebivolol.</td></tr><tr><td>B120</td><td>1</td><td>Nebivolol</td><td>Finasteride</td><td>Finasteride may decrease the antihypertensive activities of Nebivolol.</td></tr><tr><td>B120</td><td>1</td><td>Nebivolol</td><td>Valproic acid</td><td>The metabolism of Nebivolol can be decreased when combined with Valproic acid.</td></tr><tr><td>B120</td><td>1</td><td>Pantoprazole</td><td>Acetylsalicylic acid</td><td>Acetylsalicylic acid may decrease the excretion rate of Pantoprazole which could
result in a higher serum level.</td></tr><tr><td>B120</td><td>1</td><td>Pantoprazole</td><td>Lorazepam</td><td>Lorazepam may decrease the excretion rate of Pantoprazole which could result in
a higher serum level.</td></tr><tr><td>B120</td><td>1</td><td>Pantoprazole</td><td>Nebivolol</td><td>The metabolism of Nebivolol can be decreased when combined with Pantoprazole.</td></tr><tr><td>B120</td><td>1</td><td>Pantoprazole</td><td>Valproic acid</td><td>The excretion of Valproic acid can be decreased when combined with Pantoprazole.</td></tr><tr><td>B120</td><td>1</td><td>Tapentadol</td><td>Lorazepam</td><td>Tapentadol may increase the central nervous system depressant (CNS depressant)
activities of Lorazepam.</td></tr><tr><td>B120</td><td>1</td><td>Tapentadol</td><td>Methotrimeprazine</td><td>Tapentadol may increase the central nervous system depressant (CNS depressant)
activities of Methotrimeprazine.</td></tr><tr><td>B120</td><td>1</td><td>Tapentadol</td><td>Valproic acid</td><td>Tapentadol may increase the central nervous system depressant (CNS depressant)
activities of Valproic acid.</td></tr><tr><td>B120</td><td>1</td><td>Tenofovir alafenamide</td><td>Acetylsalicylic acid</td><td>The serum concentration of Tenofovir alafenamide can be increased when it is
combined with Acetylsalicylic acid.</td></tr><tr><td>B120</td><td>1</td><td>Tenofovir alafenamide</td><td>Lorazepam</td><td>The serum concentration of Tenofovir alafenamide can be decreased when it is
combined with Lorazepam.</td></tr><tr><td>B120</td><td>1</td><td>Tenofovir alafenamide</td><td>Pantoprazole</td><td>The serum concentration of Tenofovir alafenamide can be increased when it is
combined with Pantoprazole.</td></tr><tr><td>B120</td><td>1</td><td>Tenofovir alafenamide</td><td>Trazodone</td><td>The serum concentration of Tenofovir alafenamide can be decreased when it is
combined with Trazodone.</td></tr><tr><td>B120</td><td>1</td><td>Tenofovir alafenamide</td><td>Valproic acid</td><td>The serum concentration of Tenofovir alafenamide can be decreased when it is
combined with Valproic acid.</td></tr><tr><td>B120</td><td>1</td><td>Trazodone</td><td>Acetylsalicylic acid</td><td>The risk or severity of gastrointestinal bleeding can be increased when
Trazodone is combined with Acetylsalicylic acid.</td></tr><tr><td>B120</td><td>1</td><td>Trazodone</td><td>Finasteride</td><td>The risk or severity of hypertension can be increased when Trazodone is combined
with Finasteride.</td></tr><tr><td>B120</td><td>1</td><td>Trazodone</td><td>Levodopa</td><td>The risk or severity of serotonin syndrome can be increased when Trazodone is
combined with Levodopa.</td></tr><tr><td>B120</td><td>1</td><td>Trazodone</td><td>Lorazepam</td><td>The risk or severity of adverse effects can be increased when Lorazepam is
combined with Trazodone.</td></tr><tr><td>B120</td><td>1</td><td>Trazodone</td><td>Methotrimeprazine</td><td>The risk or severity of QTc prolongation can be increased when Trazodone is
combined with Methotrimeprazine.</td></tr><tr><td>B120</td><td>1</td><td>Trazodone</td><td>Nebivolol</td><td>The serum concentration of Nebivolol can be increased when it is combined with
Trazodone.</td></tr><tr><td>B120</td><td>1</td><td>Trazodone</td><td>Tapentadol</td><td>Tapentadol may increase the central nervous system depressant (CNS depressant)
activities of Trazodone.</td></tr><tr><td>B120</td><td>1</td><td>Trazodone</td><td>Valproic acid</td><td>The risk or severity of QTc prolongation can be increased when Trazodone is
combined with Valproic acid.</td></tr><tr><td>B120</td><td>1</td><td>Valproic acid</td><td>Acetylsalicylic acid</td><td>The metabolism of Valproic acid can be decreased when combined with
Acetylsalicylic acid.</td></tr><tr><td>B120</td><td>1</td><td>Valproic acid</td><td>Bictegravir</td><td>The metabolism of Bictegravir can be decreased when combined with Valproic acid.</td></tr></tbody></table></div>
